Type I insulin-like growth factor receptor signaling in skeletal muscle regeneration and hypertrophy

Journal of Musculoskeletal Neuronal Interactions

Volumn 7, Issue 3, 2007, Pages 208-218

  Philippou, A ^a,b   Halapas, A ^a   Maridaki, M ^b   Koutsilieris, M ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Adaptation; Autocrine paracrine actions; Hypertrophy; IGF 1; Muscle satelite cells; Regeneration

Indexed keywords

1,4 DIHYDROPYRIDINE RECEPTOR; CALCIUM CHANNEL L TYPE; CYCLIN D1; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; INTERLEUKIN 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MYOD1 PROTEIN; MYOGENIC FACTOR 5; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN TYROSINE KINASE; RAF PROTEIN; RAS PROTEIN; SOMATOMEDIN C RECEPTOR; TRANSCRIPTION FACTOR GATA 2;

ADAPTATION; AUTOCRINE EFFECT; AUTOPHOSPHORYLATION; BINDING AFFINITY; CELL DIFFERENTIATION; CELL PROLIFERATION; ENDOCRINE FUNCTION; EXCITATION CONTRACTION COUPLING; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MITOSIS RATE; MUSCLE EXERCISE; MUSCLE HYPERTROPHY; MUSCLE INJURY; MUSCLE REGENERATION; MYOBLAST; NONHUMAN; PARACRINE SIGNALING; PATHOPHYSIOLOGY; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; REVIEW; SATELLITE CELL; SKELETAL MUSCLE;

ANIMALS; CELL DIFFERENTIATION; HUMANS; HYPERTROPHY; INSULIN-LIKE GROWTH FACTOR I; MUSCLE, SKELETAL; MYOBLASTS; RECEPTOR, IGF TYPE 1; REGENERATION; SATELLITE CELLS, SKELETAL MUSCLE; SIGNAL TRANSDUCTION;

EID: 36949021815     PISSN: 11087161     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (133)

1. Newham D, McPhail G, Mills K, Edwards R. Ultrastructural changes after concentric and eccentric contractions of human muscle. J Neurol Sci 1983; 61:109-122.
2. Loughna PT, Goldspink DF, Goldspink G. Effect of inactivity and passive stretch on protein turnover in phasic and postural rat muscles. J Appl Physiol 1986; 61:173-179.
3. Goldspink G, Scutt A, Loughna P, Wells DJ, Jaenicke T, Gerlach GF. Gene expression in skeletal muscle in response to mechanical signals. Am J Physiol 1992; 262:R326-R363.
4. Morgan DL. New insights into the behaviour of muscle during active lengthening. Biophys J 1990; 57:209-221.
5. Brockett CL, Morgan DL, Proske U. Human hamstring muscles adapt to eccentric exercise by changing optimum length. Med Sci Sports Exerc 2001; 33:783-790.
6. Philippou A, Bogdanis GC, Nevill AM, Maridaki M. Changes in the angle-force curve of human elbow flexors following eccentric and isometric exercise. Eur J Appl Physiol 2004; 93:237-244.
7. Goldspink DF, Garlick PJ, McNurlan MA. Protein turnover measured in vivo and in vitro in muscles undergoing compensatory growth and subsequent denervation atrophy. Biochem J 1983; 210:89-98.
8. Goldspink G. Gene expression in skeletal muscle. Biochem Soc Trans 2002; 30:285-290.
9. Aagaard P. Making muscles "stronger" exercise, nutrition, drugs. J Musculoskelet Neuronal Interact 2004; 4:165-174.
10. Goldspink G, Williams P, Simpson H. Gene expression in response to muscle stretch. Clin Orthop Relat Res 2002; 403S:S146-S152.
11. Green H, Goreham C, Ouyang J, Ball Burnett M, Ranney D. Regulation of fiber size, oxidative potential, and capillarization in human muscle by resistance exercise. Am J Physiol 1999; 276:R591-R596.
12. Glass DJ. Molecular mechanisms modulating muscle mass. Trends Mol Med 2003; 9:345-350.
13. Rosenblatt JD, Yong D, Parry DJ. Satellite cell activity is required for hypertrophy of overloaded adult rat skeletal muscle. Muscle Nerve 1994; 17:608-613.
14. Allen DL, Monke SR, Talmadge RJ, Roy RR, Edgerton VR. Plasticity of myonuclear number in hypertrophied and atrophied mammalian skeletal muscle fibers. J Appl Physiol 1995; 78:1969-1976.
15. McCall GE, Allen DL, Linderman JK, Grindeland RE, Roy RR, Mukku VR, Edgerton VR. Maintenance of myonuclear domain size in rat soleus after overload and growth hormone/IGF-I treatment. J Appl Physiol 1998; 84:1407-1412.
16. Musaro A, Rosenthal N. The role of local insulin-like growth factor-1 isoforms in the pathophysiology of skeletal muscle. Curr Genom 2002; 3:149-162.
17. Barash IA, Peters D, Friden J, Lutz GJ, Lieber RL. Desmin cytoskeletal modifications after a bout of eccentric exercise in the rat. Am J Physiol Regul Integr Comp 2002; 283:R958-R963.
18. Whalen RG, Harris JB, Butler-Browne GS, Sesodia S. Expression of myosin isoforms during notexin-induced regeneration of rat soleus muscles. Dev Biol 1990; 141:24-40.
19. Peters D, Barash IA, Burdi M, Yuan PS, Mathew L, Friden J, Lieber RL. Asynchronous functional, cellular and transcriptional changes after a bout of eccentric exercise in the rat. J Physiol 2003; 553:947-957.
20. Carlson BR. The regeneration of skeletal muscle: a review. Am J Anat 1973; 137:119-150.
21. Schultz E. Satellite cell behaviour during skeletal muscle growth and regeneration. Med Sci Sports Exerc 1989; 21:S181-S186.
22. Carson JA, Nettleton D, Reecy JM. Differential gene expression in the rat soleus muscle during early work overload-induced hypertrophy. FASEB J 2002; 16:207-209.
23. Hawke TJ, Garry DJ. Myogenic satellite cells, physiology to molecular biology. J Appl Physiol 2001; 91:534-551.
24. Cameron-Smith D. Exercise and skeletal muscle gene expression. Clin Exp Pharmacol P 2002; 29:209-213.
25. Adams GR. Autocrine and/or paracrine insulin-like growth factor-I activity in skeletal muscle. Clin Orthop Relat Res 2002; 403S:S188-S196.
26. Hill M, Wernig A, Goldspink G. Muscle satellite (stem) cell activation during local tissue injury and repair. J Anat 2003; 203:89-99. 27 Mauro A. Satellite cells of skeletal muscle fibres. J Biophys Biochem Cytol 1961; 9:493-495.
27. Beauchamp JR, Heslop L, Yu DSW, Tajbakhsh S, Kelly RG, Wernig A, Buckingham ME, Partridge TA, Zammit PS. Expression of CD 34 and Myf 5 defines the majority of quiescent adult skeletal muscle satellite cells. J Cell Biol 2000; 151:1221-1233.
28. Zammit PS, Heslop L, Hudon V, Rosenblatt JD, Tajbakhsh S, Buckingham ME, Beauchamp JR, Partridge TA. Kinetics of myoblast proliferation show that resident satellite cells are competent to fully regenerate skeletal muscle fibers. Exp Cell Res 2002; 281:39-49.
29. Morgan JE, Partridge TA. Muscle satellite cells. Int J Biochem Cell Biol 2003; 35:1151-1156.
30. Seale P, Rudnicki MA. A new look at the origin, function, and "stem-cell" status of muscle satellite cells. Dev Biol 2000; 218:115-124.
31. Grounds MD, White JD, Rosenthal N, Bogoyevitch MA. The role of stem cells in skeletal and cardiac muscle repair. J Histochem Cytochem 2002; 50:589-610.
32. Stewart CE. The physiology of stem cells: potential for the elderly patient. J Musculoskelet Neuronal Interact 2004; 4:179-183.
33. Garry D, Meeson A, Elterman J, Zhao Y, Yang P, Bassel-Duby R. Myogenic stem cell function is impaired in mice lacking the forkhead/winged helix protein MNF. Proc Natl Acad Sci USA 2000; 97:5416-5421.
34. Adams GR. Invited review: autocrine/paracrine IGF-1 and skeletal muscle adaptation. J Appl Physiol 2002; 93:1159-1167.
35. Adams GR, Haddad F. The relationships among IGF-I, DNA content, and protein accumulation during skeletal muscle hypertrophy. J Appl Physiol 1996; 81:2509-2516.
36. Adams GR, McCue SA. Localized infusion of IGF-I results in skeletal muscle hypertrophy in rats. J Appl Physiol 1998; 84:1716-1722.
37. Hurme T, Kalimo H. Activation of myogenic precursor cells after muscle injury. Med Sci Sports Exerc 1992; 24:197-205.
38. Robertson TA, Papadimitriou JM, Grounds MD. Fusion between a myogenic cell in the satellite cell position and undamaged adult myofiber segments. Experientia 1992; 48:394-395.
39. Robertson TA, Papadimitriou JM, Grounds MD. Fusion of myogenic cells to the newly sealed region of damaged myofibers in skeletal muscle regeneration. Neuropathol Appl Neurobiol 1993; 19:350-358.
40. Caiozzo, VJ, Utkan A, Chou R, Khalafi A, Chandra H, Baker M, Rourke B, Adams G, Baldwin K, Green S. Effects of distraction on muscle length: mechanisms involved in sarcomerogenesis. Clin Orthop 2002; 403(Suppl.):S133-S145.
41. Robertson TA, Grounds MD, Papadimitriou JM. Elucidation of aspects of murine skeletal muscle regeneration using local and whole body irradiation. J Anat 1992; 181:265-276.
42. Barton-Davis ER, Shoturma DI, Sweeney HL. Contribution of satellite cells to IGF-I induced hypertrophy of skeletal muscle. Acta Physiol Scand 1999; 167:301-305.
43. Lowe DA, Alway SE. Stretch-induced myogenin, MyoD, and MRF4 expression and acute hypertrophy in quail slow-tonic muscle are not dependent upon satellite cell proliferation. Cell Tissue Res 1999; 296:531-539.
44. Grounds MD. Age-associated changes in the response of skeletal muscle cells to exercise and regeneration. Ann NY Acad Sci 854:78-91.
45. Stupka N, Tarnopolsky MA, Yardley NJ, Phillips SM. Cellular adaptation to repeated eccentric exercise-induced muscle damage. J Appl Physiol 2001; 91:1669-1678.
46. Fisher BD, Baracos VE, Shnitka TK, Mendryk SW, Reid DC. Ultrastructural events following acute muscle trauma. Med Sci Sports Exerc 1990; 22:185-193.
47. Mourkioti F, Rosenthal N. IGF-1, inflammation and stem cells: interactions during muscle regeneration. Trends Immunol 2005; 26:535-542.
48. Barton-Davis ER, Shoturma DI, Musaro A, Rosenthal N, Sweeney HL. Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function. Proc Natl Acad Sci USA 1998; 95:15603-15607.
49. Musaro A, McCullagh K, Paul A, Houghton L, Dobrowolny G, Molinaro M, Barton ER, Sweeney HL, Rosenthal N. Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat Genet 2001; 27:195-200.
50. Bamman MM, Shipp JR, Jiang J, Gower BA, Hunter GR, Goodman A, McLafferty CL, Urban RJ. Mechanical load increases muscle IGF-I and androgen receptor mRNA concentrations in humans. Am J Physiol Endocrinol Metab 2001; 280:E383-E390.
51. Hambrecht R, Schulze PC, Gielen S, Linke A, Mobius-Winkler S, Erbs S, Kratzsch J, Schubert A, Adams V, Schuler G. Effects of exercise training on insulin-like growth factor-I expression in the skeletal muscle of non-cachectic patients with chronic heart failure. Eur J Cardiovasc Prev Rehabil 2005; 12:401-406.
52. Bamman MM, Clarke MS, Feeback DL, Talmadge RJ, Stevens BR, Lieberman SA, Greenisen MC. Impact of resistance exercise during bed rest on skeletal muscle sarcopenia and myosin isoform distribution. J Appl Physiol 1998; 84:157-163.
53. Coleman ME, DeMayo F, Yin KC, Lee HM, Geske R, Montgomery C, Schwartz RJ. Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice. J Biol Chem 1995; 270:12109-12116.
54. Singh MA, Ding W, Manfredi TJ, Solares GS, O'Neill EF, Clements KM, Ryan ND, Kehayias JJ, Fielding RA, Evans WJ. Insulin-like growth factor I in skeletal muscle after weight-lifting exercise in frail elders. Am J Physiol 1999; 277:E135-E143.
55. Perry R, Rudnick M. Molecular mechanisms regulating myogenic determination and differentiation. Front Biosci 2000; 5:750-767.
56. Husmann I, Soulet L, Gautron J, Martelly I, Barritault D. Growth factors in skeletal muscle regeneration. Cytokine Growth Factor Rev 1996; 7:249-258.
57. Megeney LA, Kablar B, Garrett K, Anderson JE, Rudnicki MA. MyoD is required for myogenic stem cell function in adult skeletal muscle. Genes Dev 1996; 10:1173-1183.
58. Ishido M, Kami K, Masuhara M. Localization of MyoD, myogenin and cell cycle regulatory factors in hypertrophying rat skeletal muscles. Acta Physiol Scand 2004; 180:281-289.
59. Cooper RN, Tajbakhsh S, Mouly V, Cossu G, Buckingham M, Butler-Browne GS. In vivo satellite cell activation via Myf5 and MyoD in regenerating mouse skeletal muscle. J Cell Sci 1999; 112:2895-2901.
60. Grounds MD, Garrett KL, Lai MC, Wright WE, Beilharz MW. Identification of skeletal muscle precursor cells in vivo by use of MyoD1 and myogenin probes. Cell Tissue Res 1992; 267:99-104.
61. Jacobs-El J, Zhou MY, Russell B. MRF4, Myf-5, and myogenin mRNAs in the adaptive responses of mature rat muscle. Am J Physiol 1995; 268:C1045-C1052.
62. Lowe DA, Lund T, Alway SE. Hypertrophy-stimulated myogenic regulatory factor mRNA increases are attenuated in fast muscle of aged quails. Am J Physiol 1998; 275:C155-C162.
63. Cornelison DD, Wold BJ. Single-cell analysis of regulatory gene expression in quiescent and activated mouse skeletal muscle satellite cells. Dev Biol 1997; 91:270-283.
64. Rathbone CR, Wenke JC, Warren GL, Armstrong RB. Importance of satellite cells in the strength recovery after eccentric contraction-induced muscle injury. Am J Physiol Regul Integr Comp Physiol 2003; 285:R1490-1495.
65. Psilander N, Damsgaard R, Pilegaard H. Resistance exercise alters MRF and IGF-I mRNA content in human skeletal muscle. J Appl Physiol 2003; 95:1038-1044.
66. Bickel CS, Slade J, Mahoney E, Haddad F, Dudley GA, Adams GR. Time course of molecular responses of human skeletal muscle to acute bouts of resistance exercise. J Appl Physiol 2005; 98:482-488.
67. Sabourin LA, Rudnicki MA. The molecular regulation of myogenesis. Clin Genet 2000; 57:16-25.
68. Arnold HH, Winter B. Muscle differentiation: more complexity to the network of myogenic regulators. Curr Opin Genet 1998; 8:539-544.
69. Buckingham M. Skeletal muscle formation in vertebrates. Curr Opin Genet Dev 2001; 11:440-448.
70. Tureckova J, Wilson EM, Cappalonga JL, Rotwein P. Insulin-like growth factor-mediated muscle differentiation. Collaboration between phosphatidylinositol 3-kinase-akt-signaling pathways and myogenin. J Biol Chem 2001; 276:39264-39270.
71. Grounds MD, McGeachie JK. A model of myogenesis in vivo, derived from detailed autoradiographic studies of regenerating skeletal muscle, challenges the concept of quantal mitosis. Cell Tissue Res 1987; 250:563-569.
72. Yablonka-Reuveni Z, Rivera AJ. Temporal expression of regulatory and structural muscle proteins during myogenesis of satellite cells on isolated adult rat fibers. Dev Biol 1994; 164:588-603.
73. McGeachie JK, Grounds MD. Retarded myogenic cell replication in regenerating skeletal muscles of old mice: an autoradiographic study in young and old BALBc and SJL/J mice. Cell Tissue Res 1995; 280:277-282.
74. Bickel CS, Slade JM, Haddad F, Adams GR, Dudley GA. Acute molecular responses of skeletal muscle to resistance exercise in ablebodied and spinal cord-injured subjects. J Appl Physiol 2003; 94:2255-2262.
75. Haddad F, Adams GR. Selected contribution: Acute cellular and molecular responses to resistance exercise. J Appl Physiol 2002; 93:394-403.
76. Bischoff R. Chemotaxis of skeletal muscle satellite cells. Dev Dyn 1997; 208:505-515.
77. Adams GR. Role of insulin-like growth factor-1 in the regulation of skeletal muscle adaptation to increased loading. Exerc Sport Sci Rev 1998; 26:31-60.
78. Yang SY, Goldspink G. Different roles of the IGF-1 Ec peptide (MGF) and mature IGF-I in myoblast proliferation and differentiation. FEBS Lett 2002; 522:156-160.
79. Hill M, Goldspink G. Expression and splicing of the insulin-like growth factor-I gene in rodent muscle is associated with muscle satellite (stem) cell activation following local tissue damage. J Physiol 2003; 549:409-418.
80. Reyes-Moreno C, Sourla A, Choki I, Doillon C, Koutsilieris M. Osteoblast-derived survival factors protect PC-3 human prostate cancer cells from adriamycin apoptosis. Urology 1998; 52:341-347.
81. Koutsilieris M, Mitsiades C, Sourla A. Insulin-like growth factor-1 and urokinase-type plasminogen activator bioregulation system as a survival mechanism of prostate cancer cells in osteoblastic metastases: development of anti-survival factor therapy for hormone-refractory prostate cancer. Mol Med 2000; 6:251-267.
82. Koutsilieris M, Mastrogamvrakis G, Lembessis P, Sourla A, Miligos S, Michalas S. Increased insulin-like growth factor-1 activity can rescue KLE endometrial-like cells from apoptosis. Mol Med 2001; 7:20-26.
83. Bogdanos J, Karamanolakis D, Tenta R, Tsintavis A, Milathianakis C, Mitsiades C, Koutsilieris M. Endocrine/paracrine/autocrine survival factor activity of bone microenvironment participates in the development of androgen ablation and chemotherapy refractoriness of prostate cancer metastasis in skeleton. Endocr Relat Cancer 2003; 10:279-289.
84. Mitsiades CS, Mitsiades N, Koutsilieris M. The Akt pathway: molecular targets for anti-cancer drug development. Curr Cancer Drug Targets 2004; 4:235-256.
85. Tenta R, Sourla A, Lembessis P, Luu-The V, Koutsilieris M. Bone microenvironment-related growth factors, zoledronic acid and dexamethasone differentially modulate PTHrP expression in PC-3 prostate cancer cells. Horm Metab Res 2005; 37:593-601.
86. Tenta R, Sourla A, Lembessis P, Koutsilieris M. Bone-related growth factors and zoledronic acid regulate the PTHrP/PTH.1 receptor bioregulation systems in MG-63 human osteosarcoma cells. Anticancer Res 2006; 26:283-291.
87. Denley A, Cosgrove LJ, Booker GW, Wallace JC, Forbes BE. Molecular interactions of the IGF system. Cytokine Growth Factor Rev 2005; 16:421-439.
88. Adamo ML, Farrar RP. Resistance training and IGF involvement in the maintenance of muscle mass during the aging process. Ageing Res Rev 2006; 5:310-331.
89. Owino V, Yang SY, Goldspink G. Age-related loss of skeletal muscle function and the inability to express the autocrine form of insulin-like growth factor-1 (MGF) in response to mechanical overload. FEBS Lett 2001; 505:259-263.
90. Hameed M, Lange KH, Andersen JL, Schjerling P, Kjaer M, Harridge SD, Goldspink G. The effect of recombinant human growth hormone and resistance training on IGF-I mRNA expression in the muscles of elderly men. J Physiol 2004; 555:231-240.
91. Willis PE, Chadan S, Baracos V, Parkhouse WS. Acute exercise attenuates age-associated resistance to insulin-like growth factor-1. Am J Physiol 1997; 272:E397-E404.
92. Willis PE, Chadan SG, Baracos V, Parkhouse WS. Restoration of insulin-like growth factor I action in skeletal muscle of old mice. Am J Physiol 1998; 275:E525-E530.
93. Cai D, Dhe-Paganon S, Melendez PA, Lee J, Shoelson SE. Two new substrates in insulin signaling, IRS5/DOK4 and IRS6/DOK5. J Biol Chem 2003; 278:25323-25330.
94. Florini JR, Ewton DZ, Coolican SA. Growth hormone and insulin like growth factor system in myogenesis. Endocrine Rev 1996; 17:481-517.
95. Coolican SA, Samuel DS, Ewton DZ, McWade FJ, Florini JR. The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signalling pathways. J Biol Chem 1997; 272:6653-6662.
96. Canicio J, Gallardo E, Illa I, Testar X, Palacin M, Zorzano A, Kaliman P. P70 S6 kinase activation is not required for insulin-like growth factor-induced differentiation of rat, mouse or human skeletal muscle cells. Endocrinology 1998; 39:5042-5049.
97. Carrasco M, Canicio J, Palacin M, Zorzano A, Kaliman P. Identification of intracellular signaling pathways that induce myotonic dystrophy protein kinase expression during myogenesis. Endocrinology 2002; 143:3017-3025.
98. Rosenthal SM, Cheng ZQ. Opposing early and late effects of insulin-like growth factor-1 on differentiation and the cell cycle regulatory retinoblastoma protein in skeletal myoblasts. Proc Natl Acad Sci USA 1995; 92:10307-10311.
99. Glass DJ. Skeletal muscle hypertrophy and atrophy signaling pathways. Int J Biochem Cell Biol 2005; 37:1974-1984.
100. Song YH, Li Y, Du J, Mitch WE, Rosenthal N, Delafontaine P. Muscle-specific expression of IGF-I blocks angiotensin II-induced skeletal muscle wasting. J Clin Invest 2005; 115:451-458.
101. Thomas G, Hall MN. TOR signaling and control of cell growth. Curr Opin Cell Biol 1997; 9:782-787.
102. Baar K, Esser K. Phosphorylation of p70(S6k) correlates with increased skeletal muscle mass following resistance exercise. Am J Physiol 1999; 276(1Pt.1):C120-C127.
103. Chakravarthy MV, Abraha TW, Schwartz RJ, Fiorotto ML, Booth FW. Insulin-like growth factor-I extends in vitro replicative life span of skeletal muscle satellite cells by enhancing G1/S cell cycle progression via the activation of phosphatidylinositol 3′-kinase/ Akt signaling pathway. J Biol Chem 2000; 275:35942-35952.
104. Lai K-M, Gonzalez M, Poueymirou WT, Kline WO, Na E, Zlotchenko E, Stitt TN, Economides AN, Yancopoulos GD, Glass DJ. Conditional activation of akt in adult skeletal muscle induces rapid hypertrophy. Mol Cell Biol 2004; 24:9295-9304.
105. Florini JR, Ewton DZ. Highly specific inhibition of IGF-I stimulate differentiation by an antisense oligodeoxyribonucleotide to myogenin mRNA. J Biol Chem 1990; 265:13435-13437.
106. Hsu HH, Zdanowicz MM, Agarwal VR, Speiser PW. Expression of myogenic regulatory factors in normal and dystrophic mice: effects of IGF-I treatment. Biochem Mol Med 1997; 60:142-148.
107. Musaro A, Rosenthal N. Maturation of the myogenic program is induced by postmitotic expression of insulin-like growth factor I. Mol Cell Biol 1999; 19:3115-3124.
108. Sarbassov DD, Peterson CA. Insulin receptor substrate-1 and phosphatidylinositol 3-kinase regulate extracellular signal-regulated kinase-dependent and -independent signaling pathways during myogenic differentiation. Mol Endocrinol 1998; 12:1870-1878.
109. Samuel DS, Ewton DZ, Coolican SA, Petley TD, McWade FJ, Florini JR. Raf-1 activation stimulates proliferation and inhibits IGF-stimulated differentiation in L6A1 myoblasts. Horm Metab Res 1999; 31:55-64.
110. Rommel C, Clarke BA, Zimmermann S, Nunez L, Rossman R, Reid K, Moelling K, Yancopoulos GD, Glass DJ. Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt. Science 1999; 286:1738-1741.
111. Delling U, Tureckova J, Lim HW, De Windt LJ, Rotwein P, Molkentin JD. A calcineurin-NFATc3-dependent pathway regulates skeletal muscle differentiation and slow myosin heavy-chain expression. Mol Cell Biol 2000; 20:6600-6611.
112. Dobrowolny G, Giacinti C, Pelosi L, Nicoletti C, Winn N, Barberi L, Molinaro M, Rosenthal N, Musaro A. Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model. J Cell Biol 2005; 168:193-199.
113. Friday BB, Horsley V, Pavlath GK. Calcineurin activity is required for the initiation of skeletal muscle differentiation. J Cell Biol 2000; 149:657-666.
114. Musaro A, McCullagh KJ, Naya FJ, Olson EN, Rosenthal N. IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1. Nature 1999; 400:581-584.
115. Warren GL, Ingalls CP, Lowe DA, Armstrong RB. Excitation-contraction coupling: major role in contraction-induced muscle injury. Exerc Sport Sci Rev 2001; 29:82-87.
116. Lamb GD. Excitation-contraction coupling in skeletal muscle: comparisons with cardiac muscle. Clin Exp Pharmacol Physiol 2000; 27:216-224.
117. Renganathan M, Messi ML, Schwartz R, Delbono O. Over expression of IGF-1 exclusively in skeletal muscle increases the number of dihydropyridine receptors in adult transgenic mice. FEBS Lett 1997; 417:13-16.
118. 2+ channel gene expression. J Physiol 1999; 516:331-341.
119. Malbon CC, Karoor V. G-protein-linked receptors as tyrosine kinase substrates: New paradigms in signal integration. Cell Signal 1998; 10:523-527.
120. Dey BR, Spence SL, Nissley P, Furlanetto RW. Interaction of human suppressor of cytokine signalling (SOCS)-2 with the insulin-like growth factor-I receptor. J Biol Chem 1998; 273:24095-24101.
121. Gual P, Baron V, Lequoy V, Van Obberghen E. Interaction of janus kinases JAK-1 and JAK-2 with the insulin receptor and the insulin-like growth factor-1 receptor. Endocrinology 1998; 139:884-893.
122. Nieman DC. Immune response to heavy exertion. J Appl Physiol 1997; 82:1385-1394.
123. Moldoveanu AI, Shephard RJ, Shek PN. Exercise elevates plasma levels but not gene expression of IL-1β, IL-6 and TNF-α in blood mononuclear cells. J Appl Physiol 2000; 89:1499-1504.
124. Lang CH, Fan J, Coney R, Vary TC. IL-1 receptor antagonist attenuates sepsis-induced alterations in the IGF system and protein synthesis. Am J Physiol 1996; 270:E340-E437.
125. Fang CH, Li BG, James H, Fischer JE, Hasselgren PO. Cytokines block the effects of insulin-like growth factor-1 on glucose uptake and lactate production in skeletal muscle but do not influence IGF-I-induced changes in protein turnover. Shock 1997; 8:362-367.
126. Ling PR, Schwartz JH, Bistrian BR. Mechanisms of host wasting induced by administration of cytokines in rats. Am J Physiol 1997; 272:E333-E339.
127. Barbieri M, Ferrucci L, Ragno E, Corsi A, Bandinelli S, Bonafe M, Olivieri F, Giovagnetti S, Franceschi C, Guralnik JM, Paolisso G. Chronic inflammation and the effect of IGF-I on muscle strength and power in older persons. Am J Physiol Endocrinol Metab 2003; 284:E481-E487.
128. Austin L, Bower J, Kurek J, Vakakis N. Effects of leukaemia inhibitory factor and other cytokines on murine and human myoblast proliferation. J Neurol Sci 1992; 112:185-191.
129. Cantini M, Massimino ML, Rapizzi E, Rossini K, Catani C, Libera LD, and Carraro U. Human satellite cell proliferation in vitro is regulated by autocrine secretion of IL-6 stimulated by a soluble factor(s) released by activated monocytes. Biochem Biophys Res Commun 1995; 216:49-53.
130. Vierck J, O'Reilly B, Hossner K, Antonio J, Byrne K, Bucci L, Dodson M. Satellite cell regulation following myotrauma caused by resistance exercise. Cell Biol Int 2000; 24:263-272.
131. Adams GR, Haddad F, Baldwin KM. Time course of changes in markers of myogenesis in overloaded rat skeletal muscles. J Appl Physiol 1999; 87:1705-1712.
132. Livingston N, Pollare T, Lithell H, Arner P. Characterization of insulin-like growth factor-I receptor in skeletal muscles of normal and insulin resistant subjects. Diabetologia 1988; 31:871-877.
133. Siegfried JM, Kasprzyk PG, Treston AM, Mulshine JL, Quinn KA, Cuttitta F. A mitogenic peptide amide encoded within the E peptide domain of the insulin-like growth factor IB prohormone. Proc Natl Acad Sci 1992; 89:8107-8111.